[go: up one dir, main page]

CN112063736A - Rapid plasmodium detection kit and detection method based on loop-mediated isothermal amplification technology - Google Patents

Rapid plasmodium detection kit and detection method based on loop-mediated isothermal amplification technology Download PDF

Info

Publication number
CN112063736A
CN112063736A CN202010906167.XA CN202010906167A CN112063736A CN 112063736 A CN112063736 A CN 112063736A CN 202010906167 A CN202010906167 A CN 202010906167A CN 112063736 A CN112063736 A CN 112063736A
Authority
CN
China
Prior art keywords
plasmodium
detection
malaria
seq
primer set
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010906167.XA
Other languages
Chinese (zh)
Inventor
周水茂
贾西帅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Center for Disease Control and Prevention
Original Assignee
Wuhan Center for Disease Control and Prevention
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Center for Disease Control and Prevention filed Critical Wuhan Center for Disease Control and Prevention
Priority to CN202010906167.XA priority Critical patent/CN112063736A/en
Publication of CN112063736A publication Critical patent/CN112063736A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/166Oligonucleotides used as internal standards, controls or normalisation probes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to the technical field of plasmodium detection, in particular to a plasmodium rapid detection kit and a plasmodium rapid detection method based on a loop-mediated isothermal amplification technology. The kit for rapidly detecting the plasmodium based on the loop-mediated isothermal amplification technology comprises a plasmodium falciparum detection primer group reagent, a vivax malaria detection primer group reagent, a plasmodium malariae detection primer group reagent, an oval malaria detection primer group reagent, LAMP amplification reaction liquid, DNA polymerase and a color developing agent; the LAMP amplification reaction solution comprises buffer solution and dNTPs; the buffer solution contains magnesium ions and does not contain a metal chelating agent; the color developing agent comprises calcein and MnCl2. The invention can quickly and accurately identify four plasmodium species of plasmodium falciparum, plasmodium vivax, plasmodium malariae and plasmodium ovale.

Description

基于环介导等温扩增技术的疟原虫快速检测试剂盒及检测 方法Plasmodium rapid detection kit and detection based on loop-mediated isothermal amplification technology method

技术领域technical field

本发明涉及疟原虫检测技术领域,尤其涉及一种基于环介导等温扩增技术的疟原虫快速检测试剂盒及检测方法。The invention relates to the technical field of Plasmodium detection, in particular to a rapid detection kit and detection method of Plasmodium based on loop-mediated isothermal amplification technology.

背景技术Background technique

疟疾是危害人类健康和威胁生命安全的虫媒传染病,被列为全球三大公共卫生问题之一,危害人体的疟原虫主要有恶性疟(P.f)、间日疟(P.v)、三日疟(P.m)、卵形疟(P.o)4种,目前国内疟原虫的检测方法主要有显微镜镜检和荧光PCR。Malaria is an insect-borne infectious disease that threatens human health and life safety, and is listed as one of the three major public health problems in the world. (P.m) and 4 species of Plasmodium ovale (P.o). At present, the detection methods of Plasmodium in China mainly include microscopy and fluorescent PCR.

显微镜镜检为常规方法,镜检虽直观但有明显缺陷,对低疟原虫血症和混合感染敏感性不高,对检测人员的镜检经验要求较高,疟原虫镜检人员不固定,接触疟疾病例较少,镜检人员技术日渐生疏,疟疾镜检能力有退化趋势,WHO对中国疟原虫镜检能力外部评估,阴性血片、恶性疟原虫血片和间日疟原虫血片得分依次为92.5%、78.3%、70.8%,镜检漏诊和误诊较高。Microscopic examination is a routine method. Although the microscopic examination is intuitive, it has obvious defects. It is not sensitive to low malaria parasite and mixed infection. There are few malaria cases, the skills of microscopy personnel are becoming increasingly unfamiliar, and the malaria microscopy capability has a tendency to degrade. The WHO external assessment of China's Plasmodium microscopy capabilities, negative blood, Plasmodium falciparum, and Plasmodium vivax blood were scored as follows: 92.5%, 78.3%, 70.8%, the missed diagnosis and misdiagnosis were higher by microscopy.

PCR能准确鉴定疟原虫虫种,但存在费用高,且只能在设置齐全的实验室进行,实验时间长,限制了其在基层医院以及医疗条件相对较差的地区应用。PCR can accurately identify Plasmodium species, but it is expensive and can only be carried out in a well-equipped laboratory. The experimental time is long, which limits its application in primary hospitals and areas with relatively poor medical conditions.

另外,国外疟原虫的检测方法还包括恶性疟(P.f)和其它疟原虫混合LAMP方法检测试剂盒,其不能区分间日疟(P.v)、三日疟(P.m)、卵形疟(P.o)3种疟原虫虫种。In addition, foreign detection methods for Plasmodium also include P. falciparum (P.f) and other Plasmodium mixed LAMP method detection kits, which cannot distinguish between Plasmodium vivax (P.v), Plasmodium vivax (P.m), and Plasmodium ovale (P.o)3 Plasmodium species.

发明内容SUMMARY OF THE INVENTION

为了解决以上问题,本发明的目的是提供一种基于环介导等温扩增技术的疟原虫快速检测试剂盒及检测方法,能够快速、准确、鉴别恶性疟、间日疟、三日疟、卵形疟的四种疟原虫虫种。In order to solve the above problems, the purpose of the present invention is to provide a rapid detection kit and detection method for Plasmodium based on loop-mediated isothermal amplification technology, which can rapidly, accurately and accurately identify Plasmodium falciparum, P. Four Plasmodium species of Plasmodium form.

为实现上述目的,本发明所设计的基于环介导等温扩增技术的疟原虫快速检测试剂盒,其特征在于,包括恶性疟检测引物组试剂、间日疟检测引物组试剂、三日疟检测引物组试剂、卵形疟检测引物组试剂、LAMP扩增反应液、DNA聚合酶、显色剂;In order to achieve the above object, the rapid detection kit for Plasmodium based on the loop-mediated isothermal amplification technology designed in the present invention is characterized in that it includes a primer set reagent for detection of falciparum malaria, a primer set reagent for detection of vivax malaria, and a set of primer set reagents for detection of malaria vivax. Primer set reagent, ovale detection primer set reagent, LAMP amplification reaction solution, DNA polymerase, chromogenic reagent;

恶性疟检测引物组包括:Pf-FIP:SEQ ID NO1、Pf-BIP:SEQ ID NO2、Pf-F3:SEQ IDNO3、Pf-B3:SEQ ID NO4;The falciparum malaria detection primer set includes: Pf-FIP: SEQ ID NO1, Pf-BIP: SEQ ID NO2, Pf-F3: SEQ ID NO3, Pf-B3: SEQ ID NO4;

间日疟检测引物组包括:Pv-FIP:SEQ ID NO7、Pv-BIP:SEQ ID NO8、Pv-F3:SEQ IDNO9、Pv-B3:SEQ ID NO10;The primer set for detection of vivax malaria includes: Pv-FIP: SEQ ID NO7, Pv-BIP: SEQ ID NO8, Pv-F3: SEQ ID NO9, Pv-B3: SEQ ID NO10;

三日疟检测引物组包括:Pm-FIP:SEQ ID NO13、Pm-BIP:SEQ ID NO14、Pm-F3:SEQID NO15、Pm-B3:SEQ ID NO16;The three-day malaria detection primer set includes: Pm-FIP: SEQ ID NO13, Pm-BIP: SEQ ID NO14, Pm-F3: SEQ ID NO15, Pm-B3: SEQ ID NO16;

卵形疟检测引物组包括:Po-FIP:SEQ ID NO19、Po-BIP:SEQ ID NO20、Po-F3:SEQID NO21、Po-B3:SEQ ID NO22;The primer set for detection of Malaria ovale includes: Po-FIP: SEQ ID NO19, Po-BIP: SEQ ID NO20, Po-F3: SEQ ID NO21, Po-B3: SEQ ID NO22;

所述LAMP扩增反应液包括缓冲液和dNTPs;所述缓冲液中含有镁离子且不含有金属螯合剂;The LAMP amplification reaction solution includes a buffer and dNTPs; the buffer contains magnesium ions and does not contain a metal chelator;

所述显色剂包括钙黄绿素和MnCl2The color developer includes calcein and MnCl 2 .

作为优选方案,所述恶性疟检测引物组试剂还包括:Pf-LF:SEQ ID NO5、Pf-LB:SEQ ID NO6;所述间日疟检测引物组还包括Pv-LF:SEQ ID NO11、Pv-LB:SEQ ID NO12;所述三日疟检测引物组还包括Pm-LF:SEQ ID NO17、Pm-LB:SEQ ID NO18;所述卵形疟检测引物组还包括:Po-LF:SEQ ID NO23、Po-LB:SEQ ID NO24。As a preferred solution, the primer set reagents for detection of malaria falciparum also include: Pf-LF: SEQ ID NO5, Pf-LB: SEQ ID NO6; the primer set for detection of vivax malaria further includes Pv-LF: SEQ ID NO11, Pv -LB: SEQ ID NO12; the primer set for detection of Plasmodium vivax also includes Pm-LF: SEQ ID NO17, Pm-LB: SEQ ID NO18; the primer set for detection of P. ovale also includes: Po-LF: SEQ ID NO23, Po-LB: SEQ ID NO24.

作为优选方案,恶性疟检测引物组试剂包括:2.67μmol/L Pf-FIP、2.67μmol/LPf-BIP、0.33μmol/L Pf-F3、0.33μmol/L Pf-B3、0.67μmol/L Pf-LF、0.67μmol/L Pf-LB;间日疟检测引物组试剂包括:2.67μmol/L Pv-FIP、2.67μmol/L Pv-BIP、0.33μmol/L Pv-F3、0.33μmol/L Pv-B3、0.67μmol/L Pv-LF、0.67μmol/L Pv-LB;三日疟检测引物组试剂包括:2.67μmol/L Pm-FIP、2.67μmol/L Pm-BIP、0.33μmol/L Pm-F3、0.33μmol/L Pm-B3、0.67μmol/L Pm-LF、0.67μmol/L Pm-LB;卵形疟检测引物组试剂包括:2.67μmol/L Po-FIP、2.67μmol/L Po-BIP、0.33μmol/L Po-F3、0.33μmol/L Po-B3、0.67μmol/L Po-LF、0.67μmol/LPo-LB;LAMP扩增反应液包括:33.3mmol/L Tris-HCl、16.7mmol/L KCl、16.7mmol/L(NH4)2SO4、13.3mmol/L MgSO4、0.1%Triton-X100、2.3mmol/L dNTPs,LAMP扩增反应液的pH值为8.8;Bst DNA聚合酶的酶活为8000U/ml;显色剂包括0.65mmol/L钙黄绿素、7.8mmol/LMnCl2、50%二甲基亚砜。As a preferred solution, the primer set reagents for detection of falciparum malaria include: 2.67 μmol/L Pf-FIP, 2.67 μmol/L Pf-BIP, 0.33 μmol/L Pf-F3, 0.33 μmol/L Pf-B3, 0.67 μmol/L Pf-LF , 0.67μmol/L Pf-LB; vivax malaria detection primer set reagents include: 2.67μmol/L Pv-FIP, 2.67μmol/L Pv-BIP, 0.33μmol/L Pv-F3, 0.33μmol/L Pv-B3, 0.67μmol/L Pv-LF, 0.67μmol/L Pv-LB; primer set reagents for the detection of malaria malaria include: 2.67μmol/L Pm-FIP, 2.67μmol/L Pm-BIP, 0.33μmol/L Pm-F3, 0.33 μmol/L Pm-B3, 0.67 μmol/L Pm-LF, 0.67 μmol/L Pm-LB; primer set reagents for detection of Plasmodium ovale include: 2.67 μmol/L Po-FIP, 2.67 μmol/L Po-BIP, 0.33 μmol /L Po-F3, 0.33μmol/L Po-B3, 0.67μmol/L Po-LF, 0.67μmol/LPo-LB; LAMP amplification reaction solution includes: 33.3mmol/L Tris-HCl, 16.7mmol/L KCl, 16.7 mmol/L (NH 4 ) 2 SO 4 , 13.3 mmol/L MgSO 4 , 0.1% Triton-X100, 2.3 mmol/L dNTPs, the pH of the LAMP amplification reaction solution was 8.8; the enzymatic activity of Bst DNA polymerase was 8000U/ml; the developer includes 0.65mmol/L calcein, 7.8mmol/LMnCl 2 , 50% dimethyl sulfoxide.

作为优选方案,它还包括DNA提取液,所述DNA提取液包括30%H2O2、0.1mol/LNaOH、1mol/L pH8.0的Tris-HCl。As a preferred solution, it also includes a DNA extraction solution, which includes 30% H 2 O 2 , 0.1 mol/L NaOH, and 1 mol/L Tris-HCl at pH 8.0.

一种基于环介导等温扩增技术的疟原虫快速检测方法,其特征在于,包括步骤:A rapid detection method for Plasmodium based on loop-mediated isothermal amplification technology, comprising the steps of:

(1)提取待检样品的DNA;(1) Extract the DNA of the sample to be tested;

(2)环介导等温扩增:(2) Loop-mediated isothermal amplification:

(2.1)分别配制恶性疟检测体系、间日疟检测体系、三日疟检测体系和卵形疟检测体系:(2.1) Prepare the detection system of falciparum malaria, vivax malaria detection system, three-day malaria detection system and ovale malaria detection system respectively:

按体积比,LAMP扩增反应液:恶性疟检测引物组:Bst DNA聚合酶:显色剂为15:6:1:1配制得到恶性疟检测体系;According to the volume ratio, the LAMP amplification reaction solution: falciparum malaria detection primer set: Bst DNA polymerase: chromogenic reagent is 15:6:1:1 to prepare the falciparum malaria detection system;

按体积比,LAMP扩增反应液:间日疟检测引物组:Bst DNA聚合酶:显色剂为15:6:1:1配制得到间日疟检测体系;According to the volume ratio, LAMP amplification reaction solution: vivax malaria detection primer set: Bst DNA polymerase: chromogenic reagent 15:6:1:1 to prepare the vivax malaria detection system;

按体积比,LAMP扩增反应液:三日疟检测引物组:Bst DNA聚合酶:显色剂为15:6:1:1配制得到三日疟检测体系;According to the volume ratio, the LAMP amplification reaction solution: Plasmodium spp. detection primer set: Bst DNA polymerase: chromogenic reagent is 15:6:1:1 to prepare the Pseudomonas spp. detection system;

按体积比,LAMP扩增反应液:卵形疟检测引物组:Bst DNA聚合酶:显色剂为15:6:1:1配制得到卵形疟检测体系;According to the volume ratio, LAMP amplification reaction solution: Plasmodium ovale detection primer set: Bst DNA polymerase: chromogenic reagent 15:6:1:1 to prepare a detection system for Plasmodium ovale;

(2.2)将恶性疟检测体系、间日疟检测体系、三日疟检测体系和卵形疟检测体系分别置于四个PCR管中,并向每个PCR管中加入待检样品的DNA,60~65℃反应45~90分钟;观察每个PCR管中液体的颜色,呈绿色荧光为阳性,呈橙色为阴性。(2.2) Place the detection system of falciparum malaria, vivax malaria detection system, triscal malaria detection system and ovale malaria detection system in four PCR tubes respectively, and add the DNA of the sample to be tested to each PCR tube, 60 React at ~65°C for 45-90 minutes; observe the color of the liquid in each PCR tube, green fluorescence is positive, and orange is negative.

作为优选方案,取末梢血1~5μl或滤纸干血滴1~5μl置于离心管中,加入10μl的30%H2O2和50μl的0.1mol/L NaOH,95℃裂解20min后冷却至室温加入50μl的1mol/L pH8.0的Tris-HCl,混匀,即得样品的DNA。As a preferred solution, take 1-5 μl of peripheral blood or drop 1-5 μl of dried blood on filter paper into a centrifuge tube, add 10 μl of 30% H 2 O 2 and 50 μl of 0.1 mol/L NaOH, lyse at 95°C for 20 min, and cool to room temperature Add 50 μl of 1 mol/L Tris-HCl at pH 8.0 and mix well to obtain the DNA of the sample.

作为优选方案,步骤(2)具体为,恶性疟检测体系、间日疟检测体系、三日疟检测体系和卵形疟检测体系中每个体系分别设置三组平行实验,其中一组为实验组,向体系中加入待检样品的DNA,另一组为阴性对照组,向体系中加入健康人血的DNA,最后一组为空白对照组,向体系中加入去离子水;60~65℃反应45~90分钟;分别观察每个PCR管中液体的颜色。As a preferred solution, step (2) is specifically as follows: three groups of parallel experiments are set up in each of the falciparum malaria detection system, the vivax malaria detection system, the three-day malaria detection system and the ovale malaria detection system, and one group is the experimental group. , the DNA of the sample to be tested is added to the system, the other group is the negative control group, the DNA of healthy human blood is added to the system, the last group is the blank control group, and deionized water is added to the system; 60-65 ℃ reaction 45 to 90 minutes; observe the color of the liquid in each PCR tube separately.

本发明的原理为:本试剂盒针对疟原虫靶序列上的六个区域设计四条引物,即F3、B3、FIP、BIP,为了提高反应速度设计环引物LF与LB,4种疟原虫设计4组不同种的特异性引物。FIP、BIP内引物3’端和5’端分别识别靶核酸序列中2个不同区域,并设计成其5’端序列与由3’端起始的延伸反应所合成的互补链区域退火结合。FIP、BIP内引物可形成茎环结构,并进行自我延伸反应,后在环状结构位置有新的内引物退火结合并进行链置换合成反应,不断循环反复,实现扩增反应。在Bst DNA聚合酶的作用下,dNTP转化生成焦磷酸根,焦磷酸根与溶液中的镁离子反应生成大量的焦磷酸镁沉淀,在反应液中加入一种金属离子显色剂,当产生大量核酸时,钙黄绿素会自动结合到双链DNA中,由于反应液中镁离子含量不同而呈现出不同的颜色,如果发生了扩增反应,反应液就会变成绿色,若没有发生扩增反应,反应液的颜色就是橙色。The principle of the invention is as follows: the kit designs four primers for the six regions on the target sequence of the malaria parasite, namely F3, B3, FIP and BIP, and designs the loop primers LF and LB in order to improve the reaction speed, and designs four groups for the four malaria parasites. Different species-specific primers. The 3' and 5' ends of primers in FIP and BIP recognize two different regions in the target nucleic acid sequence, respectively, and are designed so that their 5' end sequences anneal and bind to the complementary chain region synthesized by the extension reaction initiated by the 3' end. The inner primers of FIP and BIP can form a stem-loop structure and carry out self-extension reaction, and then a new inner primer is annealed and combined at the position of the loop structure and undergoes a strand displacement synthesis reaction, and the cycle is repeated to realize the amplification reaction. Under the action of Bst DNA polymerase, dNTPs are converted to generate pyrophosphate, which reacts with magnesium ions in the solution to generate a large amount of magnesium pyrophosphate precipitates. A metal ion color developer is added to the reaction solution. When the nucleic acid is used, calcein will automatically bind to the double-stranded DNA, and it will show different colors due to the different content of magnesium ions in the reaction solution. If an amplification reaction occurs, the reaction solution will turn green. If no amplification reaction occurs , the color of the reaction solution is orange.

本发明的优点在于:与现有的疟原虫检测方法相比,本发明的基于环介导等温扩增技术的疟原虫快速检测试剂盒,通过设计四种疟原虫的LAMP引物组,能够识别靶核酸序列并在Bst DNA聚合酶的作用下扩增,而且通过显色剂通过肉眼可以判断阳性和阴性,能够快速、准确、鉴别恶性疟、间日疟、三日疟、卵形疟。The advantages of the present invention are: compared with the existing Plasmodium detection method, the Plasmodium rapid detection kit based on the loop-mediated isothermal amplification technology of the present invention can identify the target by designing LAMP primer sets of four types of Plasmodium. The nucleic acid sequence is amplified under the action of Bst DNA polymerase, and the positive and negative can be judged by the naked eye through the chromogenic agent, which can quickly, accurately and accurately identify falciparum malaria, vivax malaria, Triscal malaria, and ovale malaria.

附图说明Description of drawings

图1为采用本发明的试剂盒特异性检测恶性疟、间日疟、三日疟、卵形疟样品的试验结果图,1号管为患有恶性疟的人血样品、2号管为患有间日疟人血样品、3号管为患有三日疟人血样品、4号管为患有卵形疟人血样品、5号管为健康人血样品、6号管为患有利氏曼原虫人血样品、7号管为患有日本血吸虫人血样品、8号管为空白(H2O)样品;Fig. 1 is a graph of the test results of using the kit of the present invention to specifically detect samples of Plasmodium falciparum, Plasmodium vivax, Plasmodium vivax, and Plasmodium ovale. Plasmodium vivax human blood sample, tube 3 is a human blood sample with P. vivax, tube 4 is a human blood sample with P. ovale, tube 5 is a healthy human blood sample, tube 6 is a human blood sample with Leishmania, Tube No. 7 is a human blood sample with Schistosoma japonicum, and tube No. 8 is a blank (H 2 O) sample;

图2为恶性疟的环介导等温扩增效率图;其中虚线为未加显色剂浊度出峰曲线,实线为加显色剂浊度出峰曲线;Fig. 2 is the ring-mediated isothermal amplification efficiency diagram of Plasmodium falciparum; wherein the dotted line is the turbidity peak curve without adding the color developer, and the solid line is the turbidity peak curve with the color developer added;

图3为间日疟的环介导等温扩增效率图;其中虚线为未加显色剂浊度出峰曲线,实线为加显色剂浊度出峰曲线;Fig. 3 is the loop-mediated isothermal amplification efficiency diagram of Plasmodium vivax; wherein the dotted line is the turbidity peak curve without adding the color developer, and the solid line is the turbidity peak curve with the color developer added;

图4为三日疟的环介导等温扩增效率图;其中虚线为未加显色剂浊度出峰曲线,实线为加显色剂浊度出峰曲线;Fig. 4 is the loop-mediated isothermal amplification efficiency diagram of Plasmodium malariae; wherein the dotted line is the turbidity peak curve without adding the chromogenic agent, and the solid line is the turbidity peaking curve with the chromogenic agent added;

图5为卵形疟的环介导等温扩增效率图;其中虚线为未加显色剂浊度出峰曲线,实线为加显色剂浊度出峰曲线。Figure 5 is a diagram of the efficiency of ring-mediated isothermal amplification of Plasmodium ovale; the dotted line is the turbidity peak curve without the addition of the color developer, and the solid line is the turbidity peak curve with the addition of the color developer.

具体实施方式Detailed ways

为更好地理解本发明,以下将结合具体实例对发明进行详细的说明。For a better understanding of the present invention, the invention will be described in detail below with reference to specific examples.

实施例1本发明的基于环介导等温扩增技术的疟原虫快速检测试剂盒以及疟原虫的检测方法Example 1 Plasmodium rapid detection kit and detection method for Plasmodium based on loop-mediated isothermal amplification technology of the present invention

本实施例的基于环介导等温扩增技术的疟原虫快速检测试剂盒包括DNA提取液、恶性疟检测引物组试剂、间日疟检测引物组试剂、三日疟检测引物组试剂、卵形疟检测引物组试剂、LAMP扩增反应液、DNA聚合酶、显色剂;The rapid detection kit for Plasmodium based on loop-mediated isothermal amplification technology in this embodiment includes DNA extraction solution, primer set reagents for detection of Plasmodium falciparum, primer set reagents for detection of vivax malaria, primer set reagents for detection of Plasmodium ovale, Detection primer set reagent, LAMP amplification reaction solution, DNA polymerase, chromogenic reagent;

DNA提取液包括30%H2O2、0.1mol/L NaOH、1mol/L pH8.0的Tris-HCl;DNA extraction solution includes 30% H 2 O 2 , 0.1 mol/L NaOH, 1 mol/L Tris-HCl at pH 8.0;

恶性疟检测引物组试剂包括:2.67μmol/L Pf-FIP(SEQ ID NO1)、2.67μmol/L Pf-BIP(SEQ ID NO2)、0.33μmol/L Pf-F3(SEQ ID NO3)、0.33μmol/L Pf-B3(SEQ ID NO4)、0.67μmol/L Pf-LF(SEQ ID NO5)、0.67μmol/L Pf-LB(SEQ ID NO6);Plasmodium falciparum detection primer set reagents include: 2.67μmol/L Pf-FIP (SEQ ID NO1), 2.67μmol/L Pf-BIP (SEQ ID NO2), 0.33μmol/L Pf-F3 (SEQ ID NO3), 0.33μmol/ L Pf-B3 (SEQ ID NO4), 0.67 μmol/L Pf-LF (SEQ ID NO5), 0.67 μmol/L Pf-LB (SEQ ID NO6);

间日疟检测引物组试剂包括:2.67μmol/L Pv-FIP(SEQ ID NO7)、2.67μmol/L Pv-BIP(SEQ ID NO8)、0.33μmol/L Pv-F3(SEQ ID NO9)、0.33μmol/L Pv-B3(SEQ ID NO10)、0.67μmol/L Pv-LF(SEQ ID NO11)、0.67μmol/L Pv-LB(SEQ ID NO12);vivax malaria detection primer set reagents include: 2.67μmol/L Pv-FIP (SEQ ID NO7), 2.67μmol/L Pv-BIP (SEQ ID NO8), 0.33μmol/L Pv-F3 (SEQ ID NO9), 0.33μmol /L Pv-B3 (SEQ ID NO10), 0.67 μmol/L Pv-LF (SEQ ID NO11), 0.67 μmol/L Pv-LB (SEQ ID NO12);

三日疟检测引物组试剂包括:2.67μmol/L Pm-FIP(SEQ ID NO13)、2.67μmol/LPm-BIP(SEQ ID NO14)、0.33μmol/L Pm-F3(SEQ ID NO15)、0.33μmol/L Pm-B3(SEQ IDNO16)、0.67μmol/L Pm-LF(SEQ ID NO17)、0.67μmol/L Pm-LB(SEQ ID NO18);The primer set reagents for the detection of malaria malaria include: 2.67 μmol/L Pm-FIP (SEQ ID NO13), 2.67 μmol/LPm-BIP (SEQ ID NO14), 0.33 μmol/L Pm-F3 (SEQ ID NO15), 0.33 μmol/ L Pm-B3 (SEQ ID NO16), 0.67 μmol/L Pm-LF (SEQ ID NO17), 0.67 μmol/L Pm-LB (SEQ ID NO18);

卵形疟检测引物组试剂包括:2.67μmol/L Po-FIP(SEQ ID NO19)、2.67μmol/LPo-BIP(SEQ ID NO20)、0.33μmol/L Po-F3(SEQ ID NO21)、0.33μmol/L Po-B3(SEQ IDNO22)、0.67μmol/L Po-LF(SEQ ID NO23)、0.67μmol/L Po-LB(SEQ ID NO24);Plasmodium ovale detection primer set reagents include: 2.67μmol/L Po-FIP (SEQ ID NO19), 2.67μmol/LPo-BIP (SEQ ID NO20), 0.33μmol/L Po-F3 (SEQ ID NO21), 0.33μmol/ L Po-B3 (SEQ ID NO22), 0.67 μmol/L Po-LF (SEQ ID NO23), 0.67 μmol/L Po-LB (SEQ ID NO24);

LAMP扩增反应液包括:33.3mmol/L Tris-HCl、16.7mmol/L KCl、16.7mmol/L(NH4)2SO4、13.3mmol/L MgSO4、0.1%Triton-X100、2.3mmol/L dNTPs,LAMP扩增反应液的pH值为8.8;The LAMP amplification reaction solution includes: 33.3 mmol/L Tris-HCl, 16.7 mmol/L KCl, 16.7 mmol/L (NH 4 ) 2 SO 4 , 13.3 mmol/L MgSO 4 , 0.1% Triton-X100, 2.3 mmol/L dNTPs, the pH of LAMP amplification reaction solution is 8.8;

Bst DNA聚合酶的酶活为8000U/ml;The enzymatic activity of Bst DNA polymerase is 8000U/ml;

显色剂包括0.65mmol/L钙黄绿素、7.8mmol/L MnCl2、50%的二甲基亚砜。The developer includes 0.65 mmol/L calcein, 7.8 mmol/L MnCl 2 , and 50% dimethyl sulfoxide.

利用本实施例的试剂盒检测疟原虫的方法,包括步骤:The method for detecting malaria parasite using the kit of the present embodiment includes the steps:

(1)提取待检样品的DNA(1) Extract the DNA of the sample to be tested

取吸附有1~5μl血滴的滤纸片置于离心管中,加入10μl的30%H2O2和50μl的0.1mol/L NaOH,95℃裂解20min后冷却至室温加入50μl的1mol/L pH8.0的Tris-HCl,混匀,即得样品的DNA。Take the filter paper with 1-5 μl blood droplets adsorbed into a centrifuge tube, add 10 μl of 30% H 2 O 2 and 50 μl of 0.1 mol/L NaOH, lyse at 95°C for 20 min, cool to room temperature and add 50 μl of 1 mol/L pH8 .0 Tris-HCl, and mix to obtain the DNA of the sample.

(2)环介导等温扩增:(2) Loop-mediated isothermal amplification:

(2.1)配制恶性疟检测体系、间日疟检测体系、三日疟检测体系和卵形疟检测体系:(2.1) Preparation of the detection system of falciparum malaria, vivax malaria detection system, triticaria malaria detection system and ovale malaria detection system:

取LAMP扩增反应液15μl、恶性疟检测引物组6μl、Bst DNA聚合酶1μl、显色剂1μl配制得到恶性疟检测体系;Take 15 μl of LAMP amplification reaction solution, 6 μl of falciparum detection primer set, 1 μl of Bst DNA polymerase, and 1 μl of chromogenic reagent to prepare a falciparum malaria detection system;

取LAMP扩增反应液15μl、间日疟检测引物组6μl、Bst DNA聚合酶1μl、显色剂1μl配制得到间日疟检测体系;Take 15 μl of LAMP amplification reaction solution, 6 μl of vivax malaria detection primer set, 1 μl of Bst DNA polymerase, and 1 μl of chromogenic reagent to prepare a vivax malaria detection system;

取LAMP扩增反应液15μl、三日疟检测引物组6μl、Bst DNA聚合酶1μl、显色剂1μl配制得到三日疟检测体系;Take 15 μl of LAMP amplification reaction solution, 6 μl of the primer set for detection of Malaria malaria, 1 μl of Bst DNA polymerase, and 1 μl of chromogenic reagent to prepare the detection system of Malaria malaria;

取LAMP扩增反应液15μl、卵形疟检测引物组6μl、Bst DNA聚合酶1μl、显色剂1μl配制得到卵形疟检测体系;Take 15 μl of LAMP amplification reaction solution, 6 μl of oval malaria detection primer set, 1 μl of Bst DNA polymerase, and 1 μl of chromogenic reagent to prepare a detection system for ovale malaria;

分别取12只PCR管,分别编号为1、2、直至12,1至3号PCR管里分别装入恶性疟检测体系,4~6号PCR管里分别装入间日疟检测体系;7~9号管分别装入三日疟检测体系;10~12号管分别装入卵形疟检测体系。Take 12 PCR tubes and number them as 1, 2, and up to 12. The falciparum malaria detection system is placed in PCR tubes 1 to 3, and the vivax malaria detection system is placed in PCR tubes 4 to 6; 7 to 6 Tube No. 9 is respectively loaded into the detection system for Malaria ovale; tubes No. 10 to 12 are respectively loaded into the detection system for Plasmodium ovale.

(2.2)分别向12只PCR管中加入2μl待检样品的DNA,65℃反应60分钟;观察每个PCR管中液体的颜色,呈绿色荧光为阳性,呈橙色为阴性。(2.2) Add 2 μl of the DNA of the sample to be tested to 12 PCR tubes respectively, and react at 65°C for 60 minutes; observe the color of the liquid in each PCR tube, green fluorescence is positive, and orange is negative.

实施例2本发明疟原虫的检测方法的准确性Embodiment 2 Accuracy of the detection method of Plasmodium of the present invention

将16份恶性疟样品(P.f)、16份间日疟样品(P.v)、4份三日疟样品(P.m)、16份卵形疟样品(P.o)和12份健康人DNA样品分别进行传统的镜检和PCR的检测方法,其结果与本发明采用试剂盒的方法相符,说明本发明原虫的检测方法的准确性高。16 samples of P. falciparum (P.f), 16 samples of P. vivax (P.v), 4 samples of P. vivax (P.m), 16 samples of P. ovale (P.o) and 12 samples of healthy human DNA were subjected to conventional The results of the detection methods of microscopy and PCR are consistent with the method of the present invention using the kit, indicating that the detection method of the protozoa of the present invention has high accuracy.

实施例3本发明疟原虫的检测方法的敏感性Example 3 Sensitivity of the detection method for Plasmodium of the present invention

结合表1所示,本发明基于环介导等温扩增技术的疟原虫快速检测试剂盒的检测方法(以下简称LAMP)与显微镜镜检、PCR检测120例疟疾病例,全部为阳性,χ2分别为3、1,无统计学意义(P>0.05),Kappa值分别为0.961、0.987,均具有极高一致性。As shown in Table 1, the detection method (hereinafter referred to as LAMP) of the Plasmodium rapid detection kit based on the loop-mediated isothermal amplification technology of the present invention, as well as microscopic examination and PCR detection of 120 malaria cases, all were positive, and χ 2 were respectively. The Kappa values were 0.961 and 0.987, respectively, with high consistency.

表1Table 1

Figure BDA0002661541530000071
Figure BDA0002661541530000071

实施例4本发明疟原虫的检测方法的特异性Example 4 Specificity of the detection method for Plasmodium of the present invention

结合图1所示,1~4号管呈绿色,检出为阳性,5~8号管呈橙色,未检出阳性,而且利用本发明疟原虫的检测方法检测10份利氏曼原虫样品,8份日本血吸虫样品,48份健康人血样品,均呈橙色,均未检出阳性,说明本发明疟原虫的检测方法的特异性强。With reference to Fig. 1, tubes 1 to 4 are green, and the detection is positive, tubes 5 to 8 are orange, and no positive is detected, and 10 samples of Leishmania are detected by the method for detecting malaria parasite of the present invention, 8 samples of Schistosoma japonicum and 48 samples of healthy human blood were all in orange, and none of them were positive, indicating that the detection method for Plasmodium of the present invention has strong specificity.

实施例5本发明疟原虫的检测方法的灵敏度Example 5 Sensitivity of the detection method for Plasmodium of the present invention

取25000个P.f/μl血、3000个P.v/μl血、2000个P.m/μl血、4000个P.o/μl血提取的DNA分别取5μl稀释成10-1、10-2、10-3、10-4,原液至10-4DNA稀释液按LAMP操作,原液至10-3DNA稀释液4种疟原虫LAMP均变为绿色荧光,10-4DNA稀释液4种疟原虫均未出现颜色变化,经计算,P.f、P.v、P.m、P.o灵敏度分别为25、3、2、4个疟原虫/μl血。Take 25000 Pf/μl blood, 3000 Pv/μl blood, 2000 Pm/μl blood, 4000 Po/μl blood to extract 5μl of DNA and dilute them into 10 -1 , 10 -2 , 10 -3 , 10 - 4. From stock solution to 10 -4 DNA dilution solution, follow LAMP operation, from stock solution to 10 -3 DNA dilution solution, the LAMP of 4 species of Plasmodium all turned green fluorescence, and 10 -4 DNA dilution solution of 4 species of Plasmodium showed no color change. Calculated, the sensitivity of Pf, Pv, Pm, Po was 25, 3, 2, and 4 Plasmodium/μl blood, respectively.

实施例6本发明疟原虫的检测方法的重现性Example 6 Reproducibility of the detection method for Plasmodium of the present invention

P.f、P.v、P.m、P.o各4个样,分别做4个平行样,LAMP均为阳性,1个健康人和1个空白(H2O)样,各做4个平行样,结果均阴性。4 samples of Pf, Pv, Pm, Po, 4 parallel samples respectively, all LAMP positive, 1 healthy and 1 blank (H 2 O) sample, 4 parallel samples, all negative.

实施例7本发明疟原虫的检测方法的环介导等温扩增效率Example 7 Loop-mediated isothermal amplification efficiency of the detection method for Plasmodium of the present invention

结合表2以及图2、图3、图4、图5所示,LAMP经LA-500实时浊度检测系统测量,未加显色剂和加显色剂4种疟原虫LAMP浊度出峰时间分别在20-32min和26-40min之间,浊度速率峰值分别0.14-0.17和0.1-0.13之间,4种疟原虫均有较高扩增效率。Combined with Table 2 and Figure 2, Figure 3, Figure 4, Figure 5, LAMP was measured by the LA-500 real-time turbidity detection system, and the turbidity peak time of 4 kinds of Plasmodium LAMP without chromogenic agent and with chromogenic agent added Between 20-32min and 26-40min, the peak turbidity rate was between 0.14-0.17 and 0.1-0.13, respectively, and the four species of Plasmodium all had high amplification efficiency.

表2Table 2

Figure BDA0002661541530000081
Figure BDA0002661541530000081

实施例8本发明基于环介导等温扩增技术的疟原虫快速检测试剂盒的试剂保存时间Example 8 Reagent storage time of the rapid detection kit for Plasmodium based on loop-mediated isothermal amplification technology of the present invention

将试剂盒中的试剂保存1月、2月和6月后,检测8个P.f、8个P.v、5个P.m、8个P.o、8个健康人和3个空白(H2O)样,结果均相符。说明本发明试剂盒中的各试剂的保存时间可达本年以上。After storing the reagents in the kit for 1 month, 2 months and 6 months, 8 Pf, 8 Pv, 5 Pm, 8 Po, 8 healthy and 3 blank (H 2 O) samples were detected, and the results All match. It is shown that the storage time of each reagent in the kit of the present invention can reach more than this year.

综上所述,本发明基于环介导等温扩增技术的疟原虫快速检测方法,相比于目前的检测试剂盒、镜检和PCR检测的方法,具有的优点如下:To sum up, the rapid detection method for Plasmodium based on the loop-mediated isothermal amplification technology of the present invention has the following advantages compared with the current detection kits, microscopy and PCR detection methods:

(1)本发明能够同时检测和鉴别4种疟原虫(恶性疟、间日疟、三日疟、卵形疟)虫种,目前的检测试剂盒不能区分间日疟(P.v)、三日疟(P.m)、卵形疟(P.o)3种疟原虫虫种。(1) The present invention can simultaneously detect and identify 4 species of Plasmodium (P. falciparum, P. vivax, P. vivax, P. ovale), and the current detection kit cannot distinguish between P. vivax (P.v) and P. vivax (P. vivax). (P.m), Plasmodium ovale (P.o) 3 species of Plasmodium.

(2)本发明成本低、检测时间短、漏诊和误诊率低,相比于PCR检测,本发明的试剂成本不到市场疟原虫荧光PCR法的十分之一,检测时间为荧光PCR法的二分之一,相比于镜检的方法,极大地降低了漏检率。(2) The cost of the present invention is low, the detection time is short, and the rate of missed diagnosis and misdiagnosis is low. Compared with PCR detection, the cost of the reagent of the present invention is less than one tenth of that of the market Plasmodium fluorescent PCR method, and the detection time is 10 times less than that of the fluorescent PCR method. One-half, compared with the method of microscopic inspection, greatly reduces the missed detection rate.

(3)本发明具有准确率高、特异性好、灵敏度高的特点,适合大规模生产和应用。(3) The present invention has the characteristics of high accuracy, good specificity and high sensitivity, and is suitable for large-scale production and application.

以上所述实施例仅表达了本发明的几种实施方式,其描述较为具体和详细,但并不能因此而理解为对本发明专利范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进,这些都属于本发明的保护范围。因此,本发明专利的保护范围应以所附权利要求为准。The above-mentioned embodiments only represent several embodiments of the present invention, and the descriptions thereof are specific and detailed, but should not be construed as limiting the scope of the patent of the present invention. It should be pointed out that for those of ordinary skill in the art, without departing from the concept of the present invention, several modifications and improvements can also be made, which all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the appended claims.

Figure BDA0002661541530000101
Figure BDA0002661541530000101

Figure BDA0002661541530000111
Figure BDA0002661541530000111

Figure BDA0002661541530000121
Figure BDA0002661541530000121

Figure BDA0002661541530000131
Figure BDA0002661541530000131

Figure BDA0002661541530000141
Figure BDA0002661541530000141

序列表sequence listing

<110> 武汉市疾病预防控制中心<110> Wuhan Center for Disease Control and Prevention

<120> 基于环介导等温扩增技术的疟原虫快速检测试剂盒及检测方法<120> Plasmodium rapid detection kit and detection method based on loop-mediated isothermal amplification technology

<160> 24<160> 24

<170> SIPOSequenceListing 1.0<170> SIPOSequenceListing 1.0

<210> 1<210> 1

<211> 51<211> 51

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 1<400> 1

cagtatattg atattgcgtg acgaccttgc aataaataat atctagcgtg t 51cagtatattg atattgcgtg acgaccttgc aataaataat atctagcgtg t 51

<210> 2<210> 2

<211> 41<211> 41

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 2<400> 2

aactccaggc gttaacctgt aatgatcttt acgttaaggg c 41aactccaggc gttaacctgt aatgatcttt acgttaaggg c 41

<210> 3<210> 3

<211> 19<211> 19

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 3<400> 3

tattggcacc tccatgtcg 19tattggcacc tccatgtcg 19

<210> 4<210> 4

<211> 23<211> 23

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 4<400> 4

aacatttttt agtcccatgc taa 23aacatttttt agtcccatgc taa 23

<210> 5<210> 5

<211> 22<211> 22

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 5<400> 5

gtgtacaagg caacaataca cg 22gtgtacaagg caacaataca cg 22

<210> 6<210> 6

<211> 20<211> 20

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 6<400> 6

gttgagatgg aaacagccgg 20gttgagatgg aaacagccgg 20

<210> 7<210> 7

<211> 40<211> 40

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 7<400> 7

atatggtctc tcgacacggc caaattgcca tcatcttcac 40atatggtctc tcgacacggc caaattgcca tcatcttcac 40

<210> 8<210> 8

<211> 41<211> 41

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 8<400> 8

tgtgcccacc cacatactta gggaaatgtt aatggggatg t 41tgtgcccacc cacatactta gggaaatgtt aatggggatg t 41

<210> 9<210> 9

<211> 20<211> 20

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 9<400> 9

tctgttggtg gagtagatcc 20tctgttggtg gagtagatcc 20

<210> 10<210> 10

<211> 19<211> 19

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 10<400> 10

cctacgtttt ggtgaatcg 19cctacgtttt ggtgaatcg 19

<210> 11<210> 11

<211> 19<211> 19

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 11<400> 11

aggctacttc ttttgctcc 19aggctacttc ttttgctcc 19

<210> 12<210> 12

<211> 19<211> 19

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 12<400> 12

acttacagtg ctgtagaga 19acttacagtg ctgtagaga 19

<210> 13<210> 13

<211> 42<211> 42

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 13<400> 13

tattggagct ggaattaccg cgatgatggg aatttaaaac ct 42tattggagct ggaattaccg cgatgatggg aatttaaaac ct 42

<210> 14<210> 14

<211> 45<211> 45

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 14<400> 14

aattgttgca gttaaaacgc ctatgttata aatatacaaa gcatt 45aattgttgca gttaaaacgc ctatgttata aatatacaaa gcatt 45

<210> 15<210> 15

<211> 18<211> 18

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 15<400> 15

caaggccaaa ttttggtt 18caaggccaaa ttttggtt 18

<210> 16<210> 16

<211> 19<211> 19

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 16<400> 16

cggttattct taacgtaca 19cggttattct taacgtaca 19

<210> 17<210> 17

<211> 19<211> 19

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 17<400> 17

gccctccaat tgccttctg 19gccctccaat tgccttctg 19

<210> 18<210> 18

<211> 24<211> 24

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 18<400> 18

tcgtagttga atttcaagga atca 24tcgtagttga atttcaagga atca 24

<210> 19<210> 19

<211> 43<211> 43

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 19<400> 19

tattggagct ggaattaccg cgttcccaaa attcaattgg agg 43tattggagct ggaattaccg cgttcccaaa attcaattgg agg 43

<210> 20<210> 20

<211> 47<211> 47

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 20<400> 20

gttgcagtta aaacgctcgt agtgtattgt ctaagcatct tatagca 47gttgcagtta aaacgctcgt agtgtattgt ctaagcatct tatagca 47

<210> 21<210> 21

<211> 22<211> 22

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 21<400> 21

ggaatgatgg gaatttaaaa cc 22ggaatgatgg gaatttaaaa cc 22

<210> 22<210> 22

<211> 21<211> 21

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 22<400> 22

gaatgcaaag aacagatacg t 21gaatgcaaag aacagatacg t 21

<210> 23<210> 23

<211> 18<211> 18

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 23<400> 23

tgctggcacc agacttgc 18tgctggcacc agacttgc 18

<210> 24<210> 24

<211> 18<211> 18

<212> DNA<212> DNA

<213> Artificial sequence<213> Artificial sequence

<400> 24<400> 24

tgaatttcaa agaatcaa 18tgaatttcaa agaatcaa 18

Claims (7)

1.一种基于环介导等温扩增技术的疟原虫快速检测试剂盒,其特征在于,包括恶性疟检测引物组试剂、间日疟检测引物组试剂、三日疟检测引物组试剂、卵形疟检测引物组试剂、LAMP扩增反应液、DNA聚合酶、显色剂;1. a rapid detection kit for Plasmodium based on loop-mediated isothermal amplification technology, is characterized in that, comprises the detection primer set reagent of Plasmodium falciparum, the detection primer set reagent of vivax malaria, the detection primer set reagent of Malaria var. Malaria detection primer set reagent, LAMP amplification reaction solution, DNA polymerase, chromogenic reagent; 恶性疟检测引物组包括:Pf-FIP:SEQ ID NO1、Pf-BIP:SEQ ID NO2、Pf-F3:SEQ IDNO3、Pf-B3:SEQ ID NO4;The falciparum malaria detection primer set includes: Pf-FIP: SEQ ID NO1, Pf-BIP: SEQ ID NO2, Pf-F3: SEQ ID NO3, Pf-B3: SEQ ID NO4; 间日疟检测引物组包括:Pv-FIP:SEQ ID NO7、Pv-BIP:SEQ ID NO8、Pv-F3:SEQ IDNO9、Pv-B3:SEQ ID NO10;The primer set for detection of vivax malaria includes: Pv-FIP: SEQ ID NO7, Pv-BIP: SEQ ID NO8, Pv-F3: SEQ ID NO9, Pv-B3: SEQ ID NO10; 三日疟检测引物组包括:Pm-FIP:SEQ ID NO13、Pm-BIP:SEQ ID NO14、Pm-F3:SEQ IDNO15、Pm-B3:SEQ ID NO16;The three-day malaria detection primer set includes: Pm-FIP: SEQ ID NO13, Pm-BIP: SEQ ID NO14, Pm-F3: SEQ ID NO15, Pm-B3: SEQ ID NO16; 卵形疟检测引物组包括:Po-FIP:SEQ ID NO19、Po-BIP:SEQ ID NO20、Po-F3:SEQ IDNO21、Po-B3:SEQ ID NO22;The primer set for detection of Plasmodium ovale includes: Po-FIP: SEQ ID NO19, Po-BIP: SEQ ID NO20, Po-F3: SEQ ID NO21, Po-B3: SEQ ID NO22; 所述LAMP扩增反应液包括缓冲液和dNTPs;所述缓冲液中含有镁离子且不含有金属螯合剂;The LAMP amplification reaction solution includes a buffer and dNTPs; the buffer contains magnesium ions and does not contain a metal chelator; 所述显色剂包括钙黄绿素和MnCl2The color developer includes calcein and MnCl 2 . 2.根据权利要求1所述的基于环介导等温扩增技术的疟原虫快速检测试剂盒,其特征在于,所述恶性疟检测引物组试剂还包括:Pf-LF:SEQ ID NO5、Pf-LB:SEQ ID NO6;所述间日疟检测引物组还包括Pv-LF:SEQ ID NO11、Pv-LB:SEQ ID NO12;所述三日疟检测引物组还包括Pm-LF:SEQ ID NO17、Pm-LB:SEQ ID NO18;所述卵形疟检测引物组还包括:Po-LF:SEQ ID NO23、Po-LB:SEQ ID NO24。2. The rapid detection kit for Plasmodium based on loop-mediated isothermal amplification technology according to claim 1, characterized in that, the detection primer set reagent for Plasmodium falciparum further comprises: Pf-LF: SEQ ID NO5, Pf- LB: SEQ ID NO6; the vivax malaria detection primer set further includes Pv-LF: SEQ ID NO11, Pv-LB: SEQ ID NO12; the three vivax malaria detection primer set further includes Pm-LF: SEQ ID NO17, Pm-LB: SEQ ID NO18; the described P. ovale detection primer set further includes: Po-LF: SEQ ID NO23, Po-LB: SEQ ID NO24. 3.根据权利要求2所述的基于环介导等温扩增技术的疟原虫快速检测试剂盒,其特征在于,3. the rapid detection kit of Plasmodium based on loop-mediated isothermal amplification technology according to claim 2, is characterized in that, 恶性疟检测引物组试剂包括:2.67μmol/L Pf-FIP、2.67μmol/L Pf-BIP、0.33μmol/LPf-F3、0.33μmol/L Pf-B3、0.67μmol/L Pf-LF、0.67μmol/L Pf-LB;Falciparum malaria detection primer set reagents include: 2.67μmol/L Pf-FIP, 2.67μmol/L Pf-BIP, 0.33μmol/LPf-F3, 0.33μmol/L Pf-B3, 0.67μmol/L Pf-LF, 0.67μmol/ L Pf-LB; 间日疟检测引物组试剂包括:2.67μmol/L Pv-FIP、2.67μmol/L Pv-BIP、0.33μmol/LPv-F3、0.33μmol/L Pv-B3、0.67μmol/L Pv-LF、0.67μmol/L Pv-LB;vivax malaria detection primer set reagents include: 2.67μmol/L Pv-FIP, 2.67μmol/L Pv-BIP, 0.33μmol/LPv-F3, 0.33μmol/L Pv-B3, 0.67μmol/L Pv-LF, 0.67μmol /L Pv-LB; 三日疟检测引物组试剂包括:2.67μmol/L Pm-FIP、2.67μmol/L Pm-BIP、0.33μmol/LPm-F3、0.33μmol/L Pm-B3、0.67μmol/L Pm-LF、0.67μmol/L Pm-LB;The primer set reagents for the detection of malaria malaria include: 2.67μmol/L Pm-FIP, 2.67μmol/L Pm-BIP, 0.33μmol/LPm-F3, 0.33μmol/L Pm-B3, 0.67μmol/L Pm-LF, 0.67μmol /L Pm-LB; 卵形疟检测引物组试剂包括:2.67μmol/L Po-FIP、2.67μmol/L Po-BIP、0.33μmol/LPo-F3、0.33μmol/L Po-B3、0.67μmol/L Po-LF、0.67μmol/L Po-LB;Plasmodium ovale detection primer set reagents include: 2.67μmol/L Po-FIP, 2.67μmol/L Po-BIP, 0.33μmol/LPo-F3, 0.33μmol/L Po-B3, 0.67μmol/L Po-LF, 0.67μmol /L Po-LB; LAMP扩增反应液包括:33.3mmol/L Tris-HCl、16.7mmol/L KCl、16.7mmol/L(NH4)2SO4、13.3mmol/L MgSO4、0.1%Triton-X100、2.3mmol/L dNTPs,LAMP扩增反应液的pH值为8.8;The LAMP amplification reaction solution includes: 33.3 mmol/L Tris-HCl, 16.7 mmol/L KCl, 16.7 mmol/L (NH 4 ) 2 SO 4 , 13.3 mmol/L MgSO 4 , 0.1% Triton-X100, 2.3 mmol/L dNTPs, the pH of LAMP amplification reaction solution is 8.8; Bst DNA聚合酶的酶活为8000U/ml;The enzymatic activity of Bst DNA polymerase is 8000U/ml; 显色剂包括0.65mmol/L钙黄绿素、7.8mmol/L MnCl2、50%二甲基亚砜。The developer includes 0.65 mmol/L calcein, 7.8 mmol/L MnCl 2 , and 50% dimethyl sulfoxide. 4.根据权利要求1所述的基于环介导等温扩增技术的疟原虫快速检测试剂盒,它还包括DNA提取液,所述DNA提取液包括30%H2O2、0.1mol/L NaOH、1mol/L pH8.0的Tris-HCl。4. The rapid detection kit for Plasmodium based on loop-mediated isothermal amplification technology according to claim 1, further comprising a DNA extraction solution comprising 30% H 2 O 2 , 0.1 mol/L NaOH , 1 mol/L Tris-HCl at pH 8.0. 5.一种如权利要求1~4中任一项所述的基于环介导等温扩增技术的疟原虫快速检测方法,其特征在于,包括步骤:5. A rapid detection method for Plasmodium based on loop-mediated isothermal amplification technology according to any one of claims 1 to 4, characterized in that, comprising the steps of: (1)提取待检样品的DNA;(1) Extract the DNA of the sample to be tested; (2)环介导等温扩增:(2) Loop-mediated isothermal amplification: (2.1)分别配制恶性疟检测体系、间日疟检测体系、三日疟检测体系和卵形疟检测体系:(2.1) Prepare the detection system of falciparum malaria, vivax malaria detection system, three-day malaria detection system and ovale malaria detection system respectively: 按体积比,LAMP扩增反应液:恶性疟检测引物组:Bst DNA聚合酶:显色剂为15:6:1:1配制得到恶性疟检测体系;According to the volume ratio, the LAMP amplification reaction solution: falciparum malaria detection primer set: Bst DNA polymerase: chromogenic reagent is 15:6:1:1 to prepare the falciparum malaria detection system; 按体积比,LAMP扩增反应液:间日疟检测引物组:Bst DNA聚合酶:显色剂为15:6:1:1配制得到间日疟检测体系;According to the volume ratio, LAMP amplification reaction solution: vivax malaria detection primer set: Bst DNA polymerase: chromogenic reagent 15:6:1:1 to prepare the vivax malaria detection system; 按体积比,LAMP扩增反应液:三日疟检测引物组:Bst DNA聚合酶:显色剂为15:6:1:1配制得到三日疟检测体系;According to the volume ratio, the LAMP amplification reaction solution: Plasmodium spp. detection primer set: Bst DNA polymerase: chromogenic reagent is 15:6:1:1 to prepare the Pseudomonas spp. detection system; 按体积比,LAMP扩增反应液:卵形疟检测引物组:Bst DNA聚合酶:显色剂为15:6:1:1配制得到卵形疟检测体系;According to the volume ratio, LAMP amplification reaction solution: Plasmodium ovale detection primer set: Bst DNA polymerase: chromogenic reagent 15:6:1:1 to prepare a detection system for Plasmodium ovale; (2.2)将恶性疟检测体系、间日疟检测体系、三日疟检测体系和卵形疟检测体系分别置于四个PCR管中,并向每个PCR管中加入待检样品的DNA,60~65℃反应45~90分钟;观察每个PCR管中液体的颜色,呈绿色荧光为阳性,呈橙色为阴性。(2.2) Place the detection system of falciparum malaria, vivax malaria detection system, triscal malaria detection system and ovale malaria detection system in four PCR tubes respectively, and add the DNA of the sample to be tested to each PCR tube, 60 React at ~65°C for 45-90 minutes; observe the color of the liquid in each PCR tube, green fluorescence is positive, and orange is negative. 6.根据权利要求5所述疟原虫的检测方法,其特征在于,所述提取待检样品的DNA的过程为:取末梢血1~5μl或滤纸干血滴1~5μl置于离心管中,加入10μl的30%H2O2和50μl的0.1mol/L NaOH,95℃裂解20min后冷却至室温加入50μl的1mol/L pH8.0的Tris-HCl,混匀,即得样品的DNA。6. The detection method of Plasmodium according to claim 5, wherein the process of extracting the DNA of the sample to be tested is: taking 1-5 μl of peripheral blood or 1-5 μl of filter paper dried blood and placing it in a centrifuge tube, Add 10 μl of 30% H 2 O 2 and 50 μl of 0.1 mol/L NaOH, lyse at 95°C for 20 min, cool to room temperature, add 50 μl of 1 mol/L Tris-HCl pH 8.0, mix well to obtain the DNA of the sample. 7.根据权利要求5所述疟原虫的检测方法,其特征在于,它还包括设置空白对照组和阴性对照组,步骤(2)具体为,恶性疟检测体系、间日疟检测体系、三日疟检测体系和卵形疟检测体系中每个体系分别设置三组平行实验,其中一组为实验组,向体系中加入待检样品的DNA,另一组为阴性对照组,向体系中加入健康人血的DNA,最后一组为空白对照组,向体系中加入去离子水;60~65℃反应45~90分钟;分别观察每个PCR管中液体的颜色。7. the detection method of malaria parasite according to claim 5, is characterized in that, it also comprises setting blank control group and negative control group, and step (2) is specifically, falciparum malaria detection system, vivax malaria detection system, three days Three groups of parallel experiments were set up for each system in the malaria detection system and the malaria ovale detection system. One of them was an experimental group, and the DNA of the sample to be tested was added to the system, and the other group was a negative control group, and a healthy group was added to the system. DNA from human blood, the last group is a blank control group, deionized water is added to the system; the reaction is performed at 60-65°C for 45-90 minutes; the color of the liquid in each PCR tube is observed respectively.
CN202010906167.XA 2020-09-01 2020-09-01 Rapid plasmodium detection kit and detection method based on loop-mediated isothermal amplification technology Pending CN112063736A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010906167.XA CN112063736A (en) 2020-09-01 2020-09-01 Rapid plasmodium detection kit and detection method based on loop-mediated isothermal amplification technology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010906167.XA CN112063736A (en) 2020-09-01 2020-09-01 Rapid plasmodium detection kit and detection method based on loop-mediated isothermal amplification technology

Publications (1)

Publication Number Publication Date
CN112063736A true CN112063736A (en) 2020-12-11

Family

ID=73665272

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010906167.XA Pending CN112063736A (en) 2020-09-01 2020-09-01 Rapid plasmodium detection kit and detection method based on loop-mediated isothermal amplification technology

Country Status (1)

Country Link
CN (1) CN112063736A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113755621A (en) * 2021-09-02 2021-12-07 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) Isothermal amplification for detection of Plasmodium species and reagents, kits and applications
CN117512159A (en) * 2023-10-23 2024-02-06 武汉市疾病预防控制中心 A kind of Leishmania isothermal amplification detection primer and detection method
CN117947199A (en) * 2024-03-26 2024-04-30 江苏硕世生物科技股份有限公司 Primer combination and kit for distinguishing plasmodium species

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101688242A (en) * 2007-05-28 2010-03-31 国立大学法人爱媛大学 primers for detecting plasmodium
CN106801097A (en) * 2017-02-17 2017-06-06 湖北医药学院 Ring mediated isothermal amplification method based on the exclusive gene of plasmodium falciparum ring bodies
KR102004951B1 (en) * 2018-12-07 2019-08-01 대한민국 Direct LAMP kit and method for diagnosing malaria infection
CN113755621A (en) * 2021-09-02 2021-12-07 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) Isothermal amplification for detection of Plasmodium species and reagents, kits and applications

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101688242A (en) * 2007-05-28 2010-03-31 国立大学法人爱媛大学 primers for detecting plasmodium
CN106801097A (en) * 2017-02-17 2017-06-06 湖北医药学院 Ring mediated isothermal amplification method based on the exclusive gene of plasmodium falciparum ring bodies
KR102004951B1 (en) * 2018-12-07 2019-08-01 대한민국 Direct LAMP kit and method for diagnosing malaria infection
CN113755621A (en) * 2021-09-02 2021-12-07 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) Isothermal amplification for detection of Plasmodium species and reagents, kits and applications

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
周水茂等: "环介导等温扩增检测恶性疟原虫与其他疟原虫的效果评价", 《中国寄生虫学与寄生虫病杂志》, vol. 38, no. 4, pages 247 - 250 *
易海华等: "应用LAMP技术对4种疟原虫进行属种鉴定的初步研究", 《中国媒介生物学及控制杂志》, vol. 22, no. 4 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113755621A (en) * 2021-09-02 2021-12-07 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) Isothermal amplification for detection of Plasmodium species and reagents, kits and applications
CN117512159A (en) * 2023-10-23 2024-02-06 武汉市疾病预防控制中心 A kind of Leishmania isothermal amplification detection primer and detection method
CN117947199A (en) * 2024-03-26 2024-04-30 江苏硕世生物科技股份有限公司 Primer combination and kit for distinguishing plasmodium species

Similar Documents

Publication Publication Date Title
CN114752711B (en) Composition, kit and method for detecting and parting monkeypox virus and application thereof
CN112063736A (en) Rapid plasmodium detection kit and detection method based on loop-mediated isothermal amplification technology
CN112094946B (en) LAMP (loop-mediated isothermal amplification) detection primer and kit for bovine sarcoidosis virus and application of LAMP detection primer and kit
CN115109859B (en) A multimodal composite functional Helicobacter pylori nucleic acid detection test strip
CN106434989B (en) LAMP Rapid Detection Method of Tobacco Alternaria Alternaria
CN114540503A (en) Tumor suppressor Let-7a detection kit based on strand displacement and enzyme-assisted circulation signal amplification and use method thereof
CN116676423B (en) A kind of APV1 detection primer set and application
CN113755621A (en) Isothermal amplification for detection of Plasmodium species and reagents, kits and applications
CN104328209B (en) The primer of the sick WT1 Gene Detecting method of leukemia minimal residual and test kit
CN117144052B (en) Primer pair, trichophyton rubrum RPA test strip kit and detection method
CN113278736B (en) Reagents and methods for qualitative detection of bovine herpesvirus type I
CN113265479B (en) Primer composition for detecting rickettsia morganii and application thereof
CN111172314B (en) Method for detecting panax notoginseng black spot germs by LAMP
CN110295244B (en) Primer and kit for real-time fluorescence PCR detection of trypanosoma nucleic acid
CN114292903A (en) LAMP (loop-mediated isothermal amplification) multidimensional visual detection color indicator and RNA/DNA detection premix solution
CN104328213B (en) Primer and the kit of BCR-ABL fusion method for quick
CN104328210B (en) The primer of the loop-mediated isothermal amplification detection method of AML1/ETO fusion gene and test kit
CN117165715B (en) Primer pair, dermatophyte RPA test strip kit and detection method
CN111534634A (en) Visual isothermal amplification detection reagent for type II canine adenovirus and application thereof
CN105671037A (en) Probe for simply and sensitively detecting activity of exonuclease III and application of probe
CN119592703B (en) Primer, probe, kit, method and application for identifying megalobrama
CN111057788B (en) A kind of LAMP primer set and detection method for detecting Panax notoginseng rust bacteria
CN111321239B (en) LAMP primer group for detecting moniliforme and detection method
CN117286259A (en) Primer, kit and detection method for detecting schistosoma japonicum
US20210214809A1 (en) One-step detection kit for molecular diagnostics of sars-cov-2 virus

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20201211